<p>Inhaler technique errors in Romanian patients with asthma – a multicenter study</p>

Abstract

BackgroundNon-adherence to treatment is associated with poor asthma control, increased exacerbations, decline in lung function, and decreased quality of life. M-health applications have become increasingly in the last years, but little research regarding the efficiency of the instructional videos for correct inhaler use exist. The aim of this study is to assess and improve the inhalator technique and to establish which types of errors were made more often with the help of a mobile health application.Materials and methodsSeventy-five patients with partially controlled or uncontrolled asthma, using any of turbuhaler, diskus, pressurized metered dose inhaler (pMDI) or soft mist inhaler (SMI), were included in the study. When they first entered the study, the patient’s inhaler technique was assessed by a trained medical professional and the technique errors were categorized in handling, respectively inhalation errors. After the first evaluation, the patients downloaded an application on their Smartphone and were encouraged to use the application as much as needed to remind them the correct inhalation technique. The patients were re-called every three months for evaluation, treatment, and assessment of inhalation technique.ResultsWe analyzed both handling and inhalation errors for each of the four considered inhalers. We observed a significantly reduced number of inhalation technique errors after using the mobile phone application. Turbuhaler median errors were 6.00, and after six months we did not observe errors. Diskus median error was 6.00, and after six months we observed a maximum of one error. pMDI median errors were 7.00, and after six months we observed just one error. Similarly, SMI median error was 7.00, and after six months we observed just one error.ConclusionAlthough technique inhalation errors are very common among asthma patients, video instructions provided through specific mobile phone applications could improve the inhaler technique in order to achieve a better control of the disease.

The efficacy of a mobile phone application to improve adherence to treatment and self-management in people with chronic respiratory disease in Romanian population – a pilot study

“…We also observed significant differences between the ACT score of the patients group using the mobile app and the group using only the treatment stratified by gender. The ACT-T 1 scores for men patients who did not use the mobile app vs. who used the mobile app were 19.00 (19.00-20.00) vs 21.00 (20.00-22.00), p < 0.001, and in case of women patients, the scores were 20.00 (19.00-20.00) vs. 22.00 (21.00-23.00), p < 0.001. The ACT-T 2 for men patients who did not use the mobile app vs. who used the mobile app were 22.00 (20.00-Fig.…”

“…This device (Figs. 1, 2, 3, 4) has been previously successfully teste in another study that analyzed the inhaler technique errors in Romanian patients with asthma [22]. The application contains different sections that helped the patients to improve adherence to treatment and selfmanagement such as: pulmonary rehabilitation exercises, videos with inhalation devices techniques and specific questionnaires such as ACT.…”

Cardiovascular surgery complication and the benefits of pulmonary rehabilitation in preventing COPD exacerbation

“…The patient was regularly monitored, including clinical and functional assessment. In December 2012, the patient was admitted in Pulmonology department for severe infectious exacerbation of COPD with left upper lobar pneumonia and minimum left pleural effusion, cured under broad-spectrum intravenous antibiotic therapy (ceftazidime 3g/day, gentamicin 160mg / day, and (21,22). Although COPD is a progressive respiratory disease, it also has diverse manifestations beyond the lungs, known as systemic effects (23).…”

Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review)

“…While most patients with asthma achieve good control of the disease in terms of both the symptom burden (asthma symptoms, sleep disturbance and limited ability to exercise) and the risk of poor outcomes (limited lung function, frequent exacerbation, mortality and medication side-effects) ( 4 , 5 ), 5-10% experience severe symptoms and recurrent exacerbations despite maximum dose treatment with inhaled glucocorticoids and long-acting β2-agonists (LABA) ( 6 ). These patients are defined as having severe asthma and are under consideration for alternative therapies.…”